Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infection in Patients With Obesity or Diabetes: A Subgroup Analysis of Pooled Phase 3 Clinical Trials
Article in Open Forum Infectious Diseases (May 2023)
The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.
Oritavancin (KIMYRSA™) in acute bacterial skin and skin structure infections: a profile of its use in the USA
Article in Drugs & Therapy Perspectives (February 2022)
Current and future options for treating complicated skin and soft tissue infections: focus on fluoroquinolones and long-acting lipoglycopeptide antibiotics
Article in Journal of Antimicrobial Chemotherapy (November 2021)